Treatment of hemophilia B: focus on recombinant factor IX

Treatment of hemophilia B: focus on recombinant factor IX

Massimo Franchini, Francesco Frattini, Silvia Crestani, Cinzia Sissa, Carlo BonfantiDepartment of Transfusion Medicine and Hematology, Carlo Poma Hospital, Mantua, ItalyAbstract: Hemophilia B is a recessive X-linked bleeding disorder characterized by deficiency of the coagulation factor IX (FIX). In...

Full description

Bibliographic Details
Main Authors:	Franchini M, Frattini F, Crestani S, Sissa C, Bonfanti C
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-02-01
Series:	Biologics : Targets & Therapy
Online Access:	http://www.dovepress.com/treatment-of-hemophilia-b-focus-on-recombinant-factor-ix-a12186

Similar Items

GlycoPEGylated recombinant factor IX for hemophilia B in context
by: Santagostino E, et al.
Published: (2018-09-01)

Once-weekly prophylactic dosing of recombinant factor IX improves adherence in hemophilia B
by: Djambas Khayat C
Published: (2016-11-01)

Pharmacokinetic Study of Recombinant Human Factor IX in Previously Treated Patients with Hemophilia B in Taiwan
by: Hsiu-Hao Chang, et al.
Published: (2007-01-01)

Recombinant Factor IX Fc Fusion Protein Maintains Full Procoagulant Properties and Exhibits Prolonged Efficacy in Hemophilia B Mice.
by: Garabet G Toby, et al.
Published: (2016-01-01)

Autologous and Heterologous Cell Therapy for Hemophilia B toward Functional Restoration of Factor IX
by: Suvasini Ramaswamy, et al.
Published: (2018-05-01)

Prevention and Reversal of Antibody Responses Against Factor IX in Gene Therapy for Hemophilia B
by: Sushrusha eNayak, et al.
Published: (2011-12-01)

Phase 3 Clinical Trial: Perioperative Use of Nonacog Gamma, a Recombinant Factor IX, in Previously Treated Patients With Moderate/Severe Hemophilia B
by: Jerzy Windyga MD, PhD, et al.
Published: (2020-08-01)

Developments in the treatment of hemophilia B: focus on emerging gene therapy
by: Cancio MI, et al.
Published: (2013-10-01)

HEMOPHILIA INHIBITOR PATIENTS: THE USE OF RECOMBINANT FACTOR VIIa
by: Dušan Andoljšek, et al.
Published: (2004-12-01)

Evaluation of efficacy of twice-weekly prophylactic treatment with BeneFIX® (recombinant factor IX) followed by once weekly in children with severe hemophilia B: Six-year data from a local registry
by: Rafal Raad Al-Janabi, et al.
Published: (2021-01-01)

"Diagnosis of Hemophilia B Carriers, Using Taq I and Xmn I Polymorphisms of the FactorIX Gene in Iranian Individuals"
by: P Ghandil, et al.
Published: (2003-09-01)

"Diagnosis of Hemophilia B Carriers, Using Taq I and Xmn I Polymorphisms of the FactorIX Gene in Iranian Individuals"
by: P Ghandil, et al.
Published: (2003-09-01)

Critical appraisal of the role of recombinant activated factor VII in the treatment of hemophilia patients with inhibitors
by: Ampaiwan Chuansumrit, et al.
Published: (2010-03-01)

Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia A in Italy: Characteristics and Clinical Benefits
by: Mario Schiavoni, et al.
Published: (2019-12-01)

Budget impact analysis of extended half-life recombinant factor IX (rFIXFc) in the treatment of haemophilia B
by: Andrea Aiello, et al.
Published: (2020-07-01)

When engineering new recombinant factor IX molecules meets gene therapy : improvement of factor IX plasma level in patients with haemophilia B?
by: Le Quellec, Sandra
Published: (2018)

Efficient detection of factor IX mutations by denaturing high-performance liquid chromatography in Taiwanese hemophilia B patients, and the identification of two novel mutations
by: Pei-Chin Lin, et al.
Published: (2014-04-01)

Recently approved recombinant factor VIII (rFVIII) for the replacement treatment in patients with hemophilia A in Italy
by: Daniela Paola Roggeri, et al.
Published: (2017-10-01)

Potential role of a new PEGylated recombinant factor VIII for hemophilia A
by: Wynn TT, et al.
Published: (2016-06-01)

Efficacy of rFIXFc versus rIX-FP for the Treatment of Patients with Hemophilia B: Matching-Adjusted Indirect Comparison of B-LONG and PROLONG-9FP Trials
by: Astermark J, et al.
Published: (2021-07-01)

HEMOPHILIA B DIAGNOSTIC DISCREPANCY: A SURVEY TO CONFIRM THE DIAGNOSIS OF HEMOPHILIA B
by: Muhammad Tariq Masood Khan, et al.
Published: (2017-03-01)

Monitoring standard and extended half‐life products in hemophilia: Assay discrepancies for factor VIII and IX in pre‐ and postinfusion samples
by: Cecilia Augustsson, et al.
Published: (2020-10-01)

The management of hemophilia in elderly patients
by: Massimo Franchini, et al.
Published: (2007-10-01)

The Relationship of Secretion and Activity of Recombinant Factor IX with N-Glycosylation
by: Samira Khalilzadeh, et al.
Published: (2020-02-01)

A novel supplemental approach to capturing post-marketing safety information on recombinant factor VIIa in acquired hemophilia: the Acquired Hemophilia Surveillance project
by: Lentz SR, et al.
Published: (2014-01-01)

Manual therapy in the treatment of patients with hemophilia B and inhibitor
by: Rubén Cuesta-Barriuso, et al.
Published: (2018-01-01)

Real-World Early Treatment with Room Temperature–Stable Recombinant Factor VIIa in Hemophilia A/B and Inhibitors: SMART-7™ Post Hoc Analyses
by: Francesco Demartis, et al.
Published: (2017-07-01)

Hepatocyte-Like Cells Derived from Mouse Induced Pluripotent Stem Cells Produce Functional Coagulation Factor IX in a Hemophilia B Mouse Model
by: Yao-Ming Wu, et al.
Published: (2016-07-01)

Treatment of bleeding in acquired hemophilia A with the proper administration of recombinant activated factor VII: single-center study of 7 cases
by: Saito M, et al.
Published: (2016-11-01)

Fc-fusion technology and recombinant FVIII and FIX in the management of the hemophilias
by: Mancuso ME, et al.
Published: (2014-03-01)

Treatment adherence in hemophilia
by: Thornburg CD, et al.
Published: (2017-09-01)

Molecular Mechenism of hemophilia B factor IXTaipei9
by: Chia Ni Lin, et al.
Published: (1994)

Effect of Vitamin K Supplementation on Recombinant Human Factor IX Activity and Carboxylation in the Milk of Human Factor IX Transgenic Sows
by: Kuo-Cheng Yu, et al.
Published: (2012)

Mild-severe hemophilia B impacts relationships of US adults and children with hemophilia B and their families: results from the B-HERO-S study
by: Cutter S, et al.
Published: (2019-08-01)

Expression of Recombinant Factor IX Using the Transient Gene Expression Technique
by: Jafar Vatandoost, et al.
Published: (2018-12-01)

Recombinant Human Factor IX Produced from Transgenic Porcine Milk
by: Meng-Hwan Lee, et al.
Published: (2014-01-01)

Recombinant factor&nbsp;VIII in the management of hemophilia A: current use and future promise
by: Jerry S Powell
Published: (2009-05-01)

Past, present and future of hemophilia: a narrative review
by: Franchini Massimo, et al.
Published: (2012-05-01)

The molecular basis of hemophilia B : identification of the defect in factor IXVancouver
by: Geddes, Valerie Anne
Published: (2010)

Azienda Ospedaliera "Carlo Poma", Mantova
by: Francesco Frattini, et al.
Published: (2014-08-01)